Get started
RocketTickers

Astellas and Seagen Announce Positive Topline Results from Secon

Long
RocketTickers  
NASDAQ:SGEN   None
Beyond Technical Analysis
0
0
beyondta
SGEN: Astellas Pharma Inc.
2020-10-12 06:45:00
Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV® (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.